NCT04004377 (PANQOL) is a clinical trial of Scale of quality life in Acoustic Neuroma, sponsored by University Hospital, Bordeaux.

Who is sponsoring NCT04004377?

NCT04004377 is sponsored by University Hospital, Bordeaux.

What drugs are being tested in NCT04004377?

Interventions in NCT04004377: Scale of quality life.

What condition does NCT04004377 study?

NCT04004377 studies Acoustic Neuroma.

Is NCT04004377 still recruiting?

NCT04004377 is currently status unknown. Last updated 2 July 2019.

Last reviewed 2019-07-02 · How we verify

NCT04004377: PANQOL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acoustic Neuroma: Assessing the Quality of Life by the Scale PANQOL of Patients Operated or Supervised

Status unknown Last updated 2 July 2019

What this trial tests

trial testing Scale of quality life in Acoustic Neuroma in 200 participants. Status unknown.

Timeline

5 December 2018

Primary endpoint
5 December 2020

5 December 2020

Quick facts

Lead sponsor	University Hospital, Bordeaux
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	5 December 2018
Primary completion	5 December 2020
Estimated completion	5 December 2020
Sites	1 location across France

Drugs / interventions tested

Scale of quality life

Conditions studied

Acoustic Neuroma — all drugs for Acoustic Neuroma →

Sponsor

University Hospital, Bordeaux

Who can join

18 and older, any sex, with Acoustic Neuroma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study has investigated the quality of life of patients with vestibular schwannoma using this specific scale prospectively, whether treated surgically or monitored.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Acoustic Neuroma

Currently open trials in the same condition.

NCT06112509 — Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery · NA · recruiting

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

NCT07506928 — NEURO - Prognostication Using Late Somatosensory Evoked - Potentials · NA · not yet recruiting
NCT07524036 — Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan. · NA · not yet recruiting
NCT07527494 — Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction · NA · not yet recruiting
NCT07527442 — Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Va · Phase 2 · not yet recruiting
NCT07478523 — FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04004377 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Bordeaux
Last refreshed: 2 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04004377.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing